<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03863431</url>
  </required_header>
  <id_info>
    <org_study_id>R18-P222</org_study_id>
    <nct_id>NCT03863431</nct_id>
  </id_info>
  <brief_title>The Influence of Overfeeding Different Macronutrients on Whole-body Insulin Sensitivity</brief_title>
  <official_title>The Influence of Overfeeding Different Macronutrients on Whole-body Insulin Sensitivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loughborough University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loughborough University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the effect of high-carbohydrate vs. high-fat overfeeding (130% of&#xD;
      energy requirements) on whole body insulin sensitivity.&#xD;
&#xD;
      Following habitual diet, participants will be randomly allocated to either a&#xD;
      high-carbohydrate or a high-fat diet intervention for 14-days. On days 0, 7 and 14&#xD;
      participants will undergo anthropometric and metabolic testing (primarily an oral glucose&#xD;
      tolerance test [OGTT]).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Whole-body insulin sensitivity index</measure>
    <time_frame>The change between pre-, during and post- dietary interventions: Assessed on days 0, 7 and 14</time_frame>
    <description>Assessed by oral glucose tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>Day 0, Day 7, Day 14</time_frame>
    <description>Calculated from height and weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma glucose concentration</measure>
    <time_frame>Day 0, Day 7, Day 14</time_frame>
    <description>Measured in fasting plasma sample by spectrophotometric assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting serum insulin concentration</measure>
    <time_frame>Day 0, Day 7, Day 14</time_frame>
    <description>Measured in fasting serum sample by ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma lipid profile (for example total and HDL cholesterol and TAG concentrations; all measured in mmol/L)</measure>
    <time_frame>Day 0, Day 7, Day 14</time_frame>
    <description>Measured in fasting plasma sample by spectrophotometric assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Indirect calorimetry</measure>
    <time_frame>Day 0, Day 7, Day 14</time_frame>
    <description>Measured from expired gas samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective appetite ratings</measure>
    <time_frame>Day 0, Day 7, Day 14</time_frame>
    <description>Measured from visual analogue scale appetite questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Type 2 Diabetes</condition>
  <condition>Glucose Metabolism Disorders</condition>
  <condition>Metabolic Disease</condition>
  <arm_group>
    <arm_group_label>High-fat diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will consume a diet rich in fat (approximately 65% of total energy) and low in carbohydrate for 14 days.&#xD;
Measurements will be made at 0, 7 and 14 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-carbohydrate diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will consume a diet rich in carbohydrate (approximately 70% of total energy) and low in fat for 14 days.&#xD;
Measurements will be made at 0, 7 and 14 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-fat diet</intervention_name>
    <description>Participants will consume a high fat diet for 14 days with approximately 65% of energy from fat. The diet will also provide an energy excess, at 130% of energy requirements.&#xD;
Participants will be provided with all of their meals and snacks throughout the study.</description>
    <arm_group_label>High-fat diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-carbohydrate diet</intervention_name>
    <description>Participants will consume a high fat diet for 14 days with approximately 70% of energy from carbohydrate. The diet will also provide an energy excess, at 130% of energy requirements.&#xD;
Participants will be provided with all of their meals and snacks throughout the study.</description>
    <arm_group_label>High-carbohydrate diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-40 years&#xD;
&#xD;
          -  BMI = 18.5-29.9 kg/m2&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  Physically active (&gt; 3 x 30 min moderate exercise per week)&#xD;
&#xD;
          -  Non-smoker (including the use of vaporisers and e-cigarettes)&#xD;
&#xD;
          -  Healthy (determined by the School's standard health questionnaire)&#xD;
&#xD;
          -  No cardiometabolic or inflammatory illness&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Outside of age-range&#xD;
&#xD;
          -  Outside BMI range&#xD;
&#xD;
          -  Inactive (&lt; 3 x 30 min moderate exercise per week)&#xD;
&#xD;
          -  Smoker&#xD;
&#xD;
          -  Taking medication&#xD;
&#xD;
          -  History of cardiometabolic or inflammatory illness&#xD;
&#xD;
          -  Vegetarian/ vegan (as the high-fat diet is based on animal fats)&#xD;
&#xD;
          -  Other dietary restrictions which prevent consumption of the experimental diet&#xD;
&#xD;
          -  Consumption of probiotics within last 3 months (these influence the gut microbiota)&#xD;
&#xD;
          -  Participation in another clinical trial&#xD;
&#xD;
          -  Those with known or suspected food intolerances, allergies or hypersensitivity&#xD;
&#xD;
          -  Women who are known to be pregnant or who are intending to become pregnant over the&#xD;
             course of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl Hulston, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loughborough University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carl Hulston, PhD</last_name>
    <phone>+44 (0)1509 226449</phone>
    <email>c.j.hulston@lboro.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zachary Lockhead, MSc</last_name>
    <email>Z.Lockhead@Lboro.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>School of Sport, Exercise and Health Sciences</name>
      <address>
        <city>Loughborough</city>
        <state>Leicestershire</state>
        <zip>LE11 3TU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl Hulston, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 14, 2019</study_first_submitted>
  <study_first_submitted_qc>March 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loughborough University</investigator_affiliation>
    <investigator_full_name>Carl Hulston</investigator_full_name>
    <investigator_title>Senior Lecturer Nutrition and Metabolism</investigator_title>
  </responsible_party>
  <keyword>High-fat diets</keyword>
  <keyword>High-carbohydrate diets</keyword>
  <keyword>Glycaemic control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glucose Metabolism Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

